It will be useful to repeat these assays in follow-up cohorts, as well as in other psychiatric diseases, to determine whether abnormalities of SFT2D2-associated humoral immunity are limited to schizophrenia and show a state-dependent feature. This evidence concerns the gene SFT2D2 and psychiatric disorder.